Table 3 Univariate and multivariate analysis of overall survival and disease-free survival.

From: Invasive micropapillary carcinoma of the breast had no difference in prognosis compared with invasive ductal carcinoma: a propensity-matched analysis

Factors

 

Univariate analysis

Multivariate analysis

HR (95% CI)

p value

HR (95% CI)

p value

OS

Age

<35, 35~60, >60

1.343 (0.745–2.424)

0.327

2.737 (1.350–5.551)

0.005

Pathology

IMPC, IDC

0.905 (0.487–1.683)

0.752

0.727 (0.358–1.478)

0.379

TNM stage

I, II, III

3.590 (1.952–6.603)

<0.001

2.822 (1.362–5.850)

0.005

LVIa

Negative, positive

2.934 (1.133–7.601)

0.027

1.575 (0.528–4.696)

0.415

HRb status

Negative, positive

0.361 (0.176–0.738)

0.005

0.277 (0.106–0.722)

0.009

HER2c status

Negative, positive

1.083 (0.529–2.218)

0.827

0.833 (0.331–2.092)

0.697

DFS

Age

<35, 35~60, >60

0.676 (0.457–1.001)

0.051

0.888 (0.564–1.397)

0.606

Pathology

IMPC, IDC

0.901 (0.601–1.352)

0.616

0.944 (0.601–1.481)

0.802

TNM stage

I, II, III

3.082 (2.155–4.408)

<0.001

2.665 (1.731–4.103)

<0.001

LVI

Negative, positive

2.053 (1.204–3.502)

0.008

0.960 (0.513–1.799)

0.900

HR status

Negative, positive

0.786 (0.429–1.441)

0.437

1.059 (0.517–2.167)

0.876

HER2 status

Negative, positive

1.554 (1.007–2.399)

0.046

1.314 (0.798–2.166)

0.284

  1. LVIa: lymphovascular invasion.
  2. HRb: hormone receptor.
  3. HER2c: epidermal growth factor receptor 2.
Back to article page